GENEVA, Aug. 31 -- NATERA, INC. filed a patent application (US2026/014548) for “METHODS FOR LONGITUDINALLY ASSESSING DONOR-DERIVED CELL FREE DNA (DD-CFDNA) IN TRANSPLANT RECIPIENTS”. With publication no. WO/2026/177905, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12Q 1/6883
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....